169 related articles for article (PubMed ID: 31767037)
1. S100P is a molecular determinant of E-cadherin function in gastric cancer.
Carneiro P; Moreira AM; Figueiredo J; Barros R; Oliveira P; Fernandes MS; Ferro A; Almeida R; Oliveira C; Carneiro F; Schmitt F; Paredes J; Velho S; Seruca R
Cell Commun Signal; 2019 Nov; 17(1):155. PubMed ID: 31767037
[TBL] [Abstract][Full Text] [Related]
2. S100P predicts prognosis and drug resistance in gastric cancer.
Ge F; Wang C; Wang W; Wu B
Int J Biol Markers; 2013 Dec; 28(4):e387-92. PubMed ID: 23722300
[TBL] [Abstract][Full Text] [Related]
3. [Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms].
Zhao XM; Bai ZG; Ma XM; Zhang ZT; Shi XY
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):1004-8. PubMed ID: 21054985
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of S100P by lentiviral-mediated RNAi promotes apoptosis and suppresses the colony-formation ability of gastric cancer cells.
Zhang Q; Hu H; Shi X; Tang W
Oncol Rep; 2014 May; 31(5):2344-50. PubMed ID: 24677114
[TBL] [Abstract][Full Text] [Related]
5. S100P enhances the chemosensitivity of human gastric cancer cell lines.
Zhao X; Bai Z; Wu P; Zhang Z
Cancer Biomark; 2013; 13(1):1-10. PubMed ID: 23736016
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W
Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.
Li D; Zhang J; Xi Y; Zhang L; Li W; Cui J; Xing R; Pan Y; Pan Z; Li F; Lu Y
BMC Cancer; 2015 Sep; 15():637. PubMed ID: 26373288
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
[TBL] [Abstract][Full Text] [Related]
10. DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo.
Simões-Correia J; Silva DI; Melo S; Figueiredo J; Caldeira J; Pinto MT; Girão H; Pereira P; Seruca R
Hum Mol Genet; 2014 Apr; 23(8):2094-105. PubMed ID: 24293545
[TBL] [Abstract][Full Text] [Related]
11. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer.
Chan AO; Lam SK; Wong BC; Wong WM; Yuen MF; Yeung YH; Hui WM; Rashid A; Kwong YL
Gut; 2003 Apr; 52(4):502-6. PubMed ID: 12631658
[TBL] [Abstract][Full Text] [Related]
13. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
14. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin and gastric cancer: cause, consequence, and applications.
Liu X; Chu KM
Biomed Res Int; 2014; 2014():637308. PubMed ID: 25184143
[TBL] [Abstract][Full Text] [Related]
16. S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer.
Tóthová V; Gibadulinová A
Acta Virol; 2013; 57(2):238-46. PubMed ID: 23600880
[TBL] [Abstract][Full Text] [Related]
17. Functional evidence implicating S100P in prostate cancer progression.
Basu GD; Azorsa DO; Kiefer JA; Rojas AM; Tuzmen S; Barrett MT; Trent JM; Kallioniemi O; Mousses S
Int J Cancer; 2008 Jul; 123(2):330-339. PubMed ID: 18452169
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targets associated to E-cadherin dysfunction in gastric cancer.
Carneiro P; Figueiredo J; Bordeira-Carriço R; Fernandes MS; Carvalho J; Oliveira C; Seruca R
Expert Opin Ther Targets; 2013 Oct; 17(10):1187-201. PubMed ID: 23957294
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V.
Pinho SS; Figueiredo J; Cabral J; Carvalho S; Dourado J; Magalhães A; Gärtner F; Mendonfa AM; Isaji T; Gu J; Carneiro F; Seruca R; Taniguchi N; Reis CA
Biochim Biophys Acta; 2013 Mar; 1830(3):2690-700. PubMed ID: 23671930
[TBL] [Abstract][Full Text] [Related]
20. Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer.
Braungart E; Schumacher C; Hartmann E; Nekarda H; Becker KF; Höfler H; Atkinson MJ
J Pathol; 1999 Apr; 187(5):530-4. PubMed ID: 10398117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]